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1. Introduction  
Hypothyroidism, thyroid gland hormone deficiency, is quite a common disease, affecting 
more women than men. Patients with an elevated risk of hypothyroidism comprise 
postpartum women, patients affected with autoimmune diseases as well as patients with 
autoimmune family history, primary pulmonary hypertension, Down’s and Turner’s 
syndromes. The main causes of congenital hypothyroidism are endemic iodine deficiency, 
agenesis or dysgenesis of the thyroid gland and impaired synthesis of the thyroid 
hormones. The causes of the primary hypothyroidism are autoimmune thyroiditis, injury by 
surgery, irradiation or drug side effects. Secondary hypothyroidism is caused by pituitary 
adenomas, adenoma treatment by surgery or radiotherapy, tumors of the suprasellar region, 
sarcoidosis or hemochromatosis.  
Hypothyroid patients complain of cold intolerance, weight gain, constipation, dry skin, 
bradycardia, hoarseness and dementia (Roberts & Ladenson, 2004). However, thyroid 
hypofunction, and a consequent lower level of thyroid hormones in the blood, has also been 
observed in heart disease patients. In patients with acute myocardial infarction, both total 
and free levels of triiodotyronine were seen to be lower. Moreover, a transient decrease of 
tyroxine has been observed while the level of TSH was unchanged (Franklyn et al., 1984). 
Similar data was obtained on children who had undergone open heart surgery. In this case, 
decreased levels of free and total triiodothyronine, total thyroxine and TSH were observed; 
all of which, except TSH, remained depressed until the 5th to 8th days after surgery. These 
results support the statement that the pituitary-thyroid axis is suppressed in patients with 
open heart surgery (Mainwaring et al., 1994). According to the above data, a vicious circle is 
postulated (Klein  &  Ojaama, 2001; a); heart disease induces suppression of the thyroid 
gland function, which in turn, may influence the structure and function of the heart. 
The heart is composed of several cell types: cardiomyocytes, fibroblasts / myofibroblasts, 
endothelial cells and smooth muscle cells of the blood vessels. Cardiomiocytes comprise 
more than 50% of the volume of the organ and exhibit contractile properties. Cardiac 
fibroblasts comprise as much as 67% of the cells in the heart of rats. The fibroblasts are 
responsible for the synthesis and catabolism of the extracellular matrix (collagen type I and 
III, elastin and laminin),  influence the electrophysiological properties of cardiomyocytes as 
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well as regulate myocyte growth and blood vessel formation in the heart (Krenning et al., 
2010).   
The cardiovascular system remains under the regulatory influence of thyroid hormones. 
Since dysfunction of the thyroid gland results in complex changes within the heart, the 
structure and function of the heart is disturbed in both hypothyroidism and 
hyperthyroidism. Hypothyroidism affects the electrophysiological, contractile and 
hemodynamic functions of the heart and is associated with disturbances of the heart’s 
connective tissue stroma.  
The effects of thyroid hormones on the circulatory system have both genomic and non-
genomic bases. T3, triiodothyronine (3, 5, 3’-triiodo-L-thyronine), the active thyroid 
hormone, is transported to the cardiomyocyte by a specific protein situated in the cell 
membrane (Everts et al. 1996) where it is then moved to the nucleus and bound by thyroid 
nuclear receptors: two  isoforms (TR1, TR2) and three  isoforms (TR1-TR3). Of these 
isoforms, TR1 and TRbind 40% of the T3 each, and the remaining 20% is bound by the 
TR2 receptor; TR2 is unable to bind triiodothyronine. (Schwartz et.al., 1994; Kahaly & 
Dilmann, 2005). The receptor-hormone complex is bound to thyroid responsive elements 
(TRE) and, acting as gene regulator, may influence target gene expression (Brent et al., 1994). 
Several genes are upregulated by T3: the  isoform of myosin heavy chains (Morkin et al., 
1993), calcium activated ATPase (Dillman et al., 1990), 1 adrenergic receptor (Fazio et 
al.2004). The expression of other genes is inhibited by T3:  isoform of myosin heavy chains 
or phospholamban (Fazio et al. 2004). 
2. Electrophysiological function of heart  
T3 has been demonstrated to have a general regulatory effect on heart rate; bradycardia, a 
typical symptom of the patient with hypothyroidism, is related to a lowered level of 
triiodothyronine (T3). In an isolated rat atrial neonatal myocyte model, T3 was shown to 
increase the pacemaker rate mainly by elevation of the slope of spontaneous depolarization. 
Several ionic currents that may determine the pacemaker activity were considered as 
potential targets for the action of the thyroid hormones. The electrogenic Na+-Ca2+ exchange 
current (INa/Ca) density was influenced by T3 application. Thus, INa/Ca alterations by thyroid 
hormone may change the slope of the spontaneous depolarization and modify the 
pacemaker rate (Sun et al., 2001).  
The If current is defined as the current determining spontaneous diastolic depolarization 
and influence the activity of the heart pacemaker (Er et al, 2003). In vertebrates, proteins 
deriving from HCN genes form pores of the If current; three HCN isoforms have been found 
in the human heart : HCN1, HCN2 and HCN4. The experiments performed on neonatal rat 
ventricular cardiac myocytes showed that triiodothyronine (T3) evoked a positive 
chronotropic effect on spontaneously beating myocytes. In myocytes with overexpression of 
the thyroid hormone receptor TR1, increased beating activity linked with accelerated 
depolarization velocity and shortened action potential duration, as well as increased If  
current density and increased HCN2 and HCN4 transcripts and proteins were observed. 
The effect of thyroid hormones on CHN2 subunit expression is thought to be responsible for 
a positive chronotropic effect. The changes in both HCN2 and HCN4 gene expression seem 
not to be influenced by direct binding of thyroid hormone to the TREs in the promoter 
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region of the two genes. On the other hand, in cells with TR1 overexpression, lower beating 
activities, inhibition of phase 4 depolarization and prolongation of the action potential were 
found. Reduced transcription of HCN4 was also obseved (Gassanow et al., 2009). Thus, the 
thyroid hormones would apper to be involved in regulation of the heart rate, and their low 
level could be responsible for bradycardia development. 
In patients affected by hypothyroidism, atrioventricular blocks are rarely described. A 
complete atrioventricular block has been observed in a patient with severe hypothyroidism, 
complaining of bradycardia (15 beats/min), fatigue, dizziness and syncope (Schoenmakers 
et al. 2008).  In another patient, bradycardia (44 beats/min) was caused by a 2:1 
atrioventricular block with subclinical hypothyroidism (Nakayama et al., 2006). The blocks 
in two described patients were resolved after thyroxin supplementation. The functional 
blocks have been diagnosed.  
Apart from bradycardia, the typical electrocardiographical changes in hypothyroid patients 
comprise prolongation of the PQ interval, reduced QRS complex voltage, elongation of the 
QT interval and flattening or inversion of the T wave. An acquired elongation of QT with a 
tendency toward ventricular arrhythmias has also been shown in many patients affected 
with hypothyroidism. The QT interval (Fig. 1) is the marker of ventricle repolarization. 
Prolongation of the QT is usually caused by prolongation of the action potential due to a 
reduction of repolarizing currents or elevation of the inward current (Antzelvitch, 2004). In 
patients with overt primary hypothyroidism, Galetta and coworkers (2008) highlighted the 
prolongation and increased dispersion of the QT interval, partial reduction of which was 
seen after replacement therapy. In addition, the reduction of heart rate variability 
parameters seen in the study suggests a sympato-vagal imbalance in hypothyroid patients. 
An increase of QT interval dispersion was also found in women with subclinical 
hypothyroidism. The differences of QTc (- QT dispersion corrected for heart rate) were 
normalized when TSH level (>10mIU/l) was lowered (Bakiner et al., 2008). The 
cardiomyocytes isolated from hypothyroid rats are characterized by a very long action 
potential duration compared with euthyroid cardiomyocytes, however application of T3 
reduces their action potential duration by 24% (Sun et al., 2000). The mechanism of QT 
prolongation in the hypothyroid subjects is not very well explained.  However, prolongation 
of ventricular repolarisation is thought to be due to fibrous tissue accumulation in the heart 
and swelling due to excessive deposition of the osmotic compounds in the heart wall 
(Galetta et al., 2008).  
Sun et al. (2000) postulate that both the genomic and non-genomic effects of the thyroid 
hormone (T3) could be involved in the prolongation of action potential in the ventricular 
myocytes of hypothyroid rats. The genomic effects are involved with modulation of T3-
specific cardiac gene expression. Ito transient outward current density (Fig. 1) was decreased 
in the ventricular cardiomyocytes of hypothyroid rats compared to euthyroid 
cardiomyocytes; this effect is connected with reduced expression of KCND2 genes, which 
encode proteins of the voltage-dependent K+ channel Kv4.2 (Nishiyama et al.,  1998). The 
Kv4.2 and Kv4.3 gene products are molecular components determining the Ito current. Ito 
current is responsible for early repolarisation (phase 1) of action potential and is composed 
of the rapid form Ito,f and slower form reffered as Ito,s. Le Bouter and coworkers (2003) found 
reduced transcription of several genes (KCNA5, KCNB1, KCND2 KCNK2) in hypothyroid 
mice while the expression of other genes was upregulated (KCNQ1, KCNE1); these genes 
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encode the proteins of the voltage-gated K+ channel proteins. The results were confirmed on 
the protein level and were linked with reductions of Ito,f and delayed rectifying K+ current 
(Ikslow) densities and elevation of slowly activating delayed rectifier (Iks) density in 
cardiomyocytes isolated from hypothyroid mice. The thyroid hormone is thought to 
regulate the components of Ito on the transcriptional level (Shimoni & Severson, 1995). The 
reduction of Ito density could be partially responsible for prolongation of the action potential 
and QT interval elongation (Sun et al., 2000).  
 
Fig. 1. The action potential of the cardiomyocyte (lower part) and surface electrocardiogram 
(upper part). The cardiomyocyte action potential is consisted of phases 0-4 and is generated 
by following currents: INa sodium current, Ito transient outward K+ current, ICa-L voltage-
gated calcium current,  IKs slowly activating delayed rectifier current, IKr rapidly activating 
K+current, IK1 inward rectifier K+ current.  
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Ionic characteristics however are not rapidly influenced by addition of T3 to 
cardiomyocytes isolated from the hypothyroid rats, implying that changes in Ito current 
density are regulated at the transcriptional level (Sun et al., 2000). On the other hand, the 
rapid effect of T3 treatment on the Ik current, the effects being seen in only 5-15 min, 
suggests a non-genomic influence of the thyroid hormone; transcription and translation 
processes need more time (Sun et al., 2000).  Thus, different types of regulation have been 
noted for Ito and IK (delayed rectifier): transcriptional and non-genomic regulation 
respectively. Non-genomic regulation was demonstrated also for the sodium channel and 
the IK1 channel: The action potential duration was shortened by T3 application, which was 
linked with an increase of whole cell inward rectifier potassium current (IK1; Sakaguchi et 
al. 1996). Application of T3 elevated the burst activity of the sodium channel (Dudley & 
Baumgarten,1993).  
A novel genetic link between inherited long QT interval and hypothyroidism has been 
proposed by Putrell and coworkers (2010). Mutations of the KCNQ1 and KCNE2 genes are 
related to long QT interval. hERC and KCNQ1, complexed with KCNE are the subunits of 
the voltage-gated potassium channels. They generate repolarisation currents Ikr and Iks. Iks is 
the slowly activated potassium current (generated by KCNQ1,-KCNE1 subunits) and Ikr is 
the rapidly activated potassium channel (generated by hERG-KCNE2 subunits). KCNQ1 
mutations reduce ventricular muscle repolarisation capacity and prolong the QT interval. 
Furthermore, the KCNQ1-KCNE2 channel determines potassium influx to thyreocytes and 
correct accumulation of iodine ions. A mutation of KCNE could diminish the delivery of 
iodine ions to the thyreocytes, decreasing the substrate availability for thyroid hormone 
synthesis. Thus, two concomitant effects of KCNE dysfunction are observed: in the heart 
prolongation QT and possible arrhythmias, and in the thyroid gland inhibition of thyroid 
hormone synthesis and hypothyroidism formation. Hypothyroidism is associated by a 
molecular link with prolongation of QT (Purtell et al. 2010). 
Life-threatening ventricular ectopic arrhythmias are rarely seen in hypothyroid patients 
(Schenck et al. 2006); additional factors triggering sustained or life-threatening ventricular 
arrhythmias are postulated (Galetta et al., 2008). Very few reports document ventricular 
arrhythmias in the course of hypothyroidism. The “torsade de pointes’ (TdP) tachycardia 
was revealed in a few cases of women aged from 50 to 78 years affected with 
hypothyroidism with symptoms of hypometabolic crisis being commonly found. However, 
although different methods of treatment were applied, the authors stress that systematic 
therapy with thyroxine caused normalization of the electrocardiogram (Chojnowski et al. 
2007, Shojaie & Eshraghian 2008, Schenck et al. 2006). 
3. Heart contraction 
Hypothyroidism causes a reduction of heart contractility, lowers the speed of myocardial 
relaxation (Jakab et al. 1994), decreases stroke volume, ventricular feeling and cardiac 
output. In hypothyroidism, the cardiac output is decreased by 30-50%. Thus, the 
hypodynamic status of the circulatory system can be diagnosed. In a hypothyroid subject  
while the expression of  isoform of myosin heavy chains (MSH), sarcoplasmatic reticulum 
Ca2+ -ATPase (SERCa2) 1-adrenergic receptor genes is reduced due to a lowering of the 
triiodothyronine level (triiodothyronine is the factor which increases expression of these 
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genes), the expression of  isoform of myosin heavy chains (MSH) and phospholamban 
genes is increased.  
Both transcript and protein levels of MSH (known as slow myosin) are elevated in 
experimental animals with induced hypothyroidism (Haddad et al., 2003). MSH 
demonstrates low ATPase activity and works more economically (Harris et al., 1994). 
However, higher ATPase activity with a faster heart myofiber shortening velocity can be 
found in -MSH, known as fast myosin ( VanBuren et al., 1995). Domination of MSH in 
rodents impairs both diastolic and systolic heart functions. (Dillman et al., 1989, Morkin, 
1993). This phenomenon could be seen mainly in laboratory animals because the myosin 
heavy chain isoform comprises 95% of the myosin molecule in human (Gorza et al., 1984) 
and is not markedly influenced by changes of thyroid hormone level. In a hypothyroid 
patient with dilated cardiomyopathy, the cardiac output was reduced to 16% and the -
myosin heavy chain mRNA level was found to be low in biopsy samples. After 9-month 
therapy with thyroid hormone, not only was the cardiac output elevated to 37%, but the 
level of -myosin heavy chain mRNA was also increased (Ladenson et al., 1992). 
Myofibrillar ATPase activity in the heart of thyreoidectomized rats was found to be lower 
(Dowell et al., 1994) 
The adrenergic receptors in the heart remain under the positive regulatory influence of 
the thyroid hormone. In rats with experimentally-induced hypothyroidism, a decreased -
receptor number was found on cell membranes but the agonists’ affinity to the receptors 
was not changed. Isoproterenol-induced activation of adenylate cyclase was reduced 
(Dowell et al., 1994). Novotny and coworkers (1999) confirmed the reduced number of -
receptors in hypothyroid rats. Moreover, the positive inotropic effect of isoproterenol was 
reduced. These results were contrasted by Ariogla and coworkers (2009), who noted a 
reduced effect of isoproterenol and noradrenalin on heart contractility in hypothyroid 
animals, but saw increased expression of  2 and  3 receptors with no change in expression 
of  1 receptors. 
In animals with hypothyroidism, reduced pressure dvelopment (dP/dt) was linked with 
decreased phosphorylation of cardiac troponin I (cTnI) in the heart. Moreover, mRNA of 
cardiac troponin I was increased 3 fold in hearts of hypothyroid rats but mRNA of slow 
skeletal troponin I was initialy elevated but later was decreased to undedectable level in 
animals with hypothyroidism. (Averyhart-Fullard et al., 1994).  
The reduction of heart contractility due to overt hypothyroidism decreases stroke volume 
and ejection fraction. In hypothyroid patients, prolongation of the pre-ejection period and 
decrease of ventricular ejection period were observed, however these values were 
normalized after replacement therapy (Crowley 1977). Moreover, these phenomena, as well 
as bradycardia, decreases cardiac output in hypothyroid patients. 
The changes of calcium concentration in the heart are regulated by calcium activated 
ATPase and phospholamban during both systole and diastole periods. Calcium-activated 
ATPase is responsible for the calcium influx to the endoplasmatic reticulum and, in this 
way, influences the myocardial relaxation velocity (Dillman et al., 1990, Kiss et al., 1994). 
Phosholamban was found to inhibit the activity of the calcium-activated ATPase (Kiss et al. 
1994). Cardiac contractility was increased in phospholamban-deficient mice and the thyroid 
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hormone treatment was not found to increase myocardium contractility (Kiss et al. 1998). 
Triodothyronin may determine the relaxation of the heart via regulation of gene expression 
through upregulation of calcium activated ATPase and downregulation of phospholamban. 
Thus, in hypothyroidism, the gene for calcium-activated ATPase expression is decreased but 
phospholamban gene expression is increased, which will affect the systo-diastolic function 
of the heart (Fazio et al. 2004). Impairment of the diastolic function in hypothyroidism 
patients by slow myocardial relaxation of the heart results in reduction of ventricular 
feeling. Furthermore, a decreased rate of active diastolic relaxation has been found in 
hypothyroid patients (Wieshammer et al., 1989). Echocardiographic studies of hypothyroid 
patients show the modifications of the acoustic properties and myocardial fiber velocity as 
well as regional myocardial deformations. Decreased intramyocardial contractility and the 
impairment of both the active and passive diastole phases have been observed (Di Bello et 
al., 2009). In women with subclinical hypothyroidism, magnetic resonance imaging revealed 
decreased end diastolic volume – preload and increased afterload causing impaired cardiac 
performance (Ripoli et al., 2005).  
Exercise intolerance of the hypothyroid rats is related to decreased heart performance and 
increased total peripheral resistance. Lower blood flow to extensor muscles has been 
observed as well as reduced vasodilatator potential of isolated blood vessels (McAllister et 
al., 1995). Cardiac oxygen consumption measured by positron emission tomography is 
reduced in hypothyroid patients. This reduction is associated with decreased contractility 
and elevated total peripheral resistance (Bengel et al., 2000). Athea and coworkers (2007) 
investigated the effect of hypothyroidism on the cardiac energy metabolism. The maximal 
oxidative capacity of heart tissue was found to be markedly reduced, cytochrome oxidase 
and citrate synthase were inhibited  and mitochondrial cardiolipin content was lower. 
Cardiolipin influences the activity of many inner membrane proteins and its amount 
increases in mitochondria with elevated metabolic rates. Utilization of 3 phospho-glycerol, 
malate and octanoate decreased in hypothyroid animals. Additionally, while the content or 
activity of creatine kinase is not changed, it was observed to have decreased efficacy in 
hypothyroid animals, leading to impairment of mitochondrial function. However, the 
mechanism of these changes remains to be elucidated. Expression of adenine nucleotide 
transferase is reduced in hypothyroidism. This effect is linked with impairment of 
mitochondrial permeability (Paradies et al., 1997; Chavez et al., 2008). 
4. Connective tissue in the heart 
The connective tissue of the heart remains under the regulatory influence of the thyroid 
hormones. Triiodothyronine increases the intracellular transport of amino acids, sugars and 
calcium and increases protein synthesis. However, interstitial fibrosis with excessive 
glycosaminoglycan accumulation was found on histological examination of a hypothyroid 
heart (Mohr-Kahaly et al. 1996). Additoinally, echocardiography showed changes of the 
heart structure in hypothyroid patients. The alterations could be the result of excessive 
accumulation of collagen, water retention or changes of the muscle fiber orientation 
(Monzani et al., 2001).  
Ciulla and coworkers (2004) investigated the collagen content in the heart of hypothyroid 
patients with echocardiographical studies. The derived collagen volume fraction (dCVF% 
echocardiographical evaluation of the collagen content in the heart) was evaluated. Higher 
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values of dCFV% were found in hypothyroid hearts, but echoreflectivity was normalized 
after thyroid hormone treatment. Experiments performed on rats with induced 
hypothyroidism by thyroidectomy or 4-methyl-2-thiouracil application demonstrated 
increased accumulation of collagen and glycosaminoglycans in the hearts of two groups 
with experimental hypothyreosis (Drobnik et al., 2009). Moreover, an increased level of 
hialuronic acid was found in hypothyroid rats in the heart and the hindlimb muscle (Wiig et 
al., 2000). An elevated level of hyaluronan was also noted in human fibroblasts cultured in 
conditions without thyroid hormones (Shishiba et al., 1988). 
The mechanism of the observed changes remains a matter of debate. The elevation of the 
extracellular matrix in the hypothyroid heart is supposed to be related to a low level of 
thyroid hormones and reduced catabolism of extracellular compounds. Decreased 
hydroxyproline levels, the marker of collagen, were noticed in the urine and serum of 
hypothyroid subjects; these changes were normalized by replacement therapy. 
Additionally, decreased collagen degradation was confirmed in hypothyroid subjects by 
experiments with radiolabeled proline. Most importantly however, the final effect of the 
thyroid status would seem to be dependent on the target organ; increased collagen 
content was noted in both the skin and liver of the hypothyroid animals as well as a 
decreased collagen level in the bones (Kucharz, 1992). Previous results showed decreased 
collagen catabolism in hypothyroid animals, and this effect may explain the elevation of 
collagen level in the heart.  
However, in primary hypothyroidism, a low level of the thyroid hormone is accompanied 
with an elevation of TSH, which is thought to influence the regulation of the connective 
tissue matrix in the heart. Although an increased number of cells was found in 
myofibroblast cultures isolated from newborn rat heart after TSH application, the level of 
collagen or glycosaminoglycans in the culture was unchanged; this elevation of 
myofibroblast number in TSH-treated cultures raises the question of whether a TSH-
dependent effect could be responsible for connective tissue accumulation in the hypothyroid 
heart (Drobnik et al., 2009). Application of immunoglobulin from the sera of patients with 
Graves’ disease increases collagen biosynthesis, which is explained by immunoglobulin 
binding to the TSH receptors (Kohn & Winand, 1975). Experimental outcomes prove that the 
TSH receptor transcript is present in the human heart (Koshiyama et al., 1996). TSH receptor 
transcripts and receptor immunoreactivity were found in fibroblasts of different origins 
(Daumiere et al., 2002; Feliciello et al., 1993). Collagen accumulation in the heart is 
responsible for the increased stiffness of the heart wall and may contribute to diastolic heart 
failure development.  
Excessive glycosaminoglycan accumulation in the skin is linked with myxedema formation 
(Smith et al., 1989). Wiig and coworkers (2000) found increased interstitial fluid pressure in 
the skin and muscle in hypothyroid rats. Thus, accumulation of glycosaminoglycans and 
proteins in the interstitial space is supposed to increase the edema of the interstitium.  
While pleural or pericardial effusions are noted in 10% to 30% of the adult hypothyroidism 
patients, this complication is rare in children (Martinez-Soto et al., 2010). The main 
symptoms of cardiac tamponade in hypothyroid patients are increased or normal heart rate 
(after pericardiocentesis, the tempo is slowed) distant heart sounds, enlarged jugular veins, 
low P valves, T valves and QRS complex in the electrocardiogram and massive pericardial 
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effusion in echocardiography. The following mechanisms of the cardiac tamponade are 
possible: increased permeability in microcirculation, leakage of fluid with high protein 
concentration and disturbed lymphatic drainage. The cardiac tamponade is a rare 
complication of hypothyroidism because of the slow liquid accumulation and high 
distensibility of the pericardium (Lin et al., 2003). 
5. Blood vessel 
Low cardiac output and decreased blood pressure was noted in hypothyroid subjects 
however, increased total peripheral resistance was also noticed. On the other hand, diastolic 
hypertension was observed in 25% of the patients. Hypertension has been linked with 
increased systemic vascular resistance (Klein &  Ojama, 2001; b). However, experimental 
hypertension could be reversed by hypothyroidism (Vargas et al., 1988).  
The pressor response for vasoconstrictors and vasodilatators changes in the hypothyroid 
subject (Vargas et al., 2006). A reduced pressor response to noradrenalin has been proven in 
normotensive hypothyroid patients, suggesting a decreased sensitivity of blood vessels to 
noradrenalin, however, the response of blood vessels to noradrenalin become normal after 
thyroxin supplementation. Interestingly, in hypertensive hypothyroid patients, the 
sensitivity of blood vessel to noradrenalin was found to be normal (Bramnert et al., 1994). 
Similarly, aortic rings with an intact endothelium has been proven to demonstrate a reduced 
pressor response to phenylephrine (Pantes et al., 2006). The reduced sensitivity of blood 
vessels to 1 stimulators is thought to be due to a decreased number of 1-adrenoreceptors 
in tested samples (Vargas et al., 2006).  Reduced arteries sensitivity to nitric oxide donors 
(sodium nitroprusside) has also been reported. Infusion of nitroprusside caused lower 
elevation of forearm blood flow in hypothyroid patients comparing with healthy subjects 
(Napoli et al., 2009). Moreover, both acetylcholine or histamine-induced vasodilatation was 
seen to be lower in hypothyroid rats but nitric oxide independent vasodilatation remained 
unchanged  (Moreno et al., 2003).  
Inhibited vasodilatation by endothelium dependent factors is thought to be responsible for 
the increased total peripheral vascular resistance seen in hypothyroid subjects (Vargas et al., 
2006). Human smooth muscle cells are postulated to be targets for the thyroid hormones. 
The genomic and non-genomic mechanisms of thyroid hormones may well play a role in the 
regulation of smooth muscle cell contractility. However, the molecular targets are not 
known (Klein & Ojama, 2001; b). In hypothyroidism, a lower level of plasma renin 
concentration (Bouhnik et al., 1981) increased vasopressin level (Arnaout et al., 1992) and 
decreased concentration of atrial natriuretic peptide (Kohno et al., 1987) were observed.  
Reduced activity of the thyroid gland was observed in subjects affected by hypertension. 
The inhibition of thyroid activity is supposed to be related to the thyroid-depressing factor 
found in the liver, spleen, kidney and plasma, which was released during hypertension 
development in rats. This thyroid-depressing factor reduces thyroid activity mainly by 
inhibiting the binding of 131I and blocking thyrotropin-stimulated 131I binding (Fregly & 
Threatte 1982; Vargas et al., 2006).  
In hypothyroid patients elevation of total cholesterol, low-density lipoprotein (LDL) as well 
as the apo B levels was observed (Staub et al., 1992). These results could be explained by 
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lowered number of LDL receptors. Thus, decreased level of mRNA for LDL receptor in the 
liver of hypothyroid rats was found; however this effect was reversed by thyroxine 
treatment (Staels et al., 1990). In hypothyroid women the LDL catabolism was decreased 
(Thompson et al., 1981). The genomic effects of the thyroid hormones on LDL receptor 
expression were proved (Bakker et al., 1998). The gene coding of the LDL receptor is 
positively regulated by thyroid hormones.  
Patients affected with overt hypothyroidism are influenced by several risk factors of 
atherosclerosis: elevated levels of low-density lipoprotein, total cholesterol, diastolic 
hypertension and elevated coagulability. Higher prevalence of atherosclerotic changes in 
aorta and myocardial infarction in women with subclinical hypothyroidism was observed 
(Hak et al., 2000). On the other hand, the thyroid hormone supplementation could be 
responsible for exacerbation of the ischemic heart disease due to positive chronotropic and 
inotropic effects (Roberts and Ladenson 2004) 
6. Summary 
The paper shows that hypothyroidism is responsible for profound disturbances in the 
structure and function of the cardiovascular system. The symptoms of hypothyroidism 
comprise heart arrhythmias (bradycardia, atrioventricular block, tachycardia, torsade de 
points) and disturbances in myocardium contraction and relaxation, as well as decrease of 
oxygen consumption. Molecular mechanism of symptoms has been described. Decreased 
thyroid hormone content influences the mechanisms of the development of 
hypothyroidism symptoms through both genomic and non-genomic effects. Elevation of 
TSH is thought to be involved in some of the peripheral effects observed in rats with 
primary hypothyroidism. In patients with heart disease, hypothyroidism should be 
considered as a possible cause. 
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